drugset / Trial / NCT03432793
Drug-Drug Interaction (DDI) Study for TD-9855
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to assess the effect of fluvoxamine, itraconazole and smoking on the PK disposition of multiple doses TD-9855 in healthy male subjects. The study will also assess the relationship between caffeine PK and TD-9855 PK disposition in healthy male smokers and non-smokers.
Timeline
- Start
- 2018-02-28
- Primary completion
- 2018-04-21
- Completion
- 2018-04-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caffeine | Small molecule | — | Oral |
| Subject | Fluvoxamine | Unknown | — | Oral |
| Subject | Itraconazole | Small molecule | — | Oral |
| Subject | ampreloxetine | Small molecule | — | Oral |
Indications
No indication recorded.